Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Iqvia

Is IQVIA Holdings Stock Underperforming the Nasdaq?

IQVIA Holdings has considerably underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like IQVIA Holdings Stock?

IQVIA Holdings has underperformed the broader market over the past year, but Wall Street analysts are bullish about the stock’s prospects.

Barchart

IQVIA Holdings' Quarterly Earnings Preview: What You Need to Know

With IQVIA Holdings gearing up to release its third-quarter earnings later this month, analysts project a double-digit surge in earnings.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Iqvia Bolts Higher After A Surprise Segment Beat Saved Its Second Quarter

Iqvia stock bolted higher Monday after the contract research firm raised its outlook for the year on the back of unexpected strength.

Investors Business Daily

Best Strong Buy Stocks for a Stock Picker's Market

Current market conditions have folks seeking out sturdy investment opportunities. These Strong Buy stocks are a good place to start.

Kiplinger

What's behind shortages of Adderall, Ozempic and other meds?

Drug shortages are growing in the United States, and experts see no clear path to resolving them

The Independent UK

The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat

Millions of people are scrambling to navigate the Adderall shortage in a saga closely watched by investors in Teva and other drug stocks. Here's what you should know.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Adderall shortage puts U.S. on brink of public health crisis

A rise in demand for Adderall has triggered a shortage of the drug.

Axios

BLRX: September NDA

By John Vandermosten, CFA NASDAQ:BLRX READ THE FULL BLRX RESEARCH REPORT

Benzinga

Maker of Dolo-650, pandemic’s ‘magic pill’, faces income tax searches and PIL petitions

National trade union of medical representatives cites paracetamol to make a case against unethical marketing practices of pharma companies

The Hindu

Saudi Arabia, US Sign 18 Agreements in Energy, Other Areas

Saudi Arabia and the United States signed 18 partnership agreements in fields including energy, communications, space and healthcare during a visit by US President Joe Biden. The agreements include deals with US aerospace and defense firms Boeing and Raytheon, as well as healthcare companies Medtronic, Digital Diagnostics, and IQVIA, according…

Asharq Al-Awsat

Investors Seem To Be Unmoved By IQVIA's Street Lagging Estimates, Q1 Surpass Expectations

IQVIA Holdings Inc (NYSE:IQV) posted Q1 sales of $3.57 billion, up 4.7% on a reported basis and 6.8% at constant currency (CC), slightly above the consensus of $3.55 billion. Technology & Analytics Solutions revenue increased 6.8% (9.8% CC) to $1.44 billion. Research & Development Solutions (R&DS) sales reached $1.93 billion, +3.5% (4.7%…

Benzinga

3 Beaten-Down Growth Stocks to Snatch Up in Q2 2022

Despite no clarity on when the Russia-Ukraine war will end, surging inflation, and logistical hindrances, the U.S. economy looks sufficiently resilient to weather the crises. Given this backdrop, we think shares of beaten-down growth stocks IQVIA (IQV), West Pharmaceutical (WST), and Synopsys (SNPS) could soar in price in the coming…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

SP Global Market Intelligence

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.